Status:
COMPLETED
Evaluation of Topical Antipsoriatics in the Psoriasis Plaque Test
Lead Sponsor:
Technische Universität Dresden
Conditions:
Psoriasis Vulgaris
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the efficacy of the topical therapies Protopic and Advantan as well as their combination against placebo in a Psoriasis Plaque Test
Detailed Description
daily psoriasis plaque tests for two weeks and optical coherence tomography (OCT) and 20-MHz-ultrasound on day 0 and day 11, 10 days post end of treatment and 20 days post end of treatment
Eligibility Criteria
Inclusion
- Patients older than 18 Years
- Negative urine pregnancy test
- Written informed consent
- Good compliance
Exclusion
- Patients less than 18 years
- Pregnant patients
- Patients with renal insufficiency, liver diseases
- Patients who received systemic antipsoriatic treatment or UV treatment less than 4 weeks prior to study
- Patients who used topical antipsoriatics within two weeks prior to study
- Immunosuppressed Patients
Key Trial Info
Start Date :
September 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT00236171
Start Date
September 1 2004
End Date
June 1 2010
Last Update
June 8 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Technische Universität Dresden
Dresden, Saxony, Germany, 0351